 |
 |
|
 |
 |
Targeted Radiotherapy
Radioimmunotherapy (RIT)
for Lymphoma
Jack W. Singer M.D.
Chief Medical Officer
Cell Therapeutics, Inc.
Clinical Professor of Medicine
University of Washington
Targeted Radiotherapy
Radioimmunotherapy (RIT)
for Lymphoma
Jack W. Singer M.D.
Chief Medical Officer
Cell Therapeutics, Inc.
Clinical Professor of Medicine
University of Washington
|